Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

2 ArticlesNATCOPHARM

1 / 1

Earnings Report Closing Piece : 3QFY17 : 663 Companies Till Date With Management Comments!

Here is a quick summary of the 3QFY17 financial results for all the companies announced till date. This is the final results piece for 3QFY17 having covered ...

Feb 23, 2017

3QFY17-Communication-Services-23022017.png

We Reveal The Observations Made By US FDA’s Inspection Of Natco’s Kothur Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...

Jan 25, 2017

Natco-Kothur-483.png

Join Capitalmind Premium

Starts at ₹1,999/mo

Get access to our equity, fixed income, macro and personal finance research, model equity and fixed-income portfolios, exclusive apps, tutorials, and member community.